...
首页> 外文期刊>Human Pathology >Lynch syndrome-associated colorectal carcinoma: Frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach
【24h】

Lynch syndrome-associated colorectal carcinoma: Frequent involvement of the left colon and rectum and late-onset presentation supports a universal screening approach

机译:林奇综合征相关的大肠癌:左结肠和直肠的频繁受累和迟发性表现支持一种通用的筛查方法

获取原文
获取原文并翻译 | 示例

摘要

The optimal strategy for screening patients with colorectal carcinoma for Lynch syndrome (LS) is a subject of continued debate in the literature with some advocating universal screening while others arguing for selective screening. We evaluated 1292 colorectal carcinomas for DNA mismatch repair protein abnormalities and identified 150 (11.6%) tumors demonstrating high-levels of microsatellite instability (MSI-H). MSI-H colorectal carcinomas were divided into sporadic (112/1292, 8.7%) and LS/probable LS-associated (38/1292, 2.9%) groups based on BRAF V600E mutation, MLH1 promoter hypermethylation, cancer history, and germline mismatch repair gene mutation. All MSI-H colorectal carcinomas were analyzed for grade, location, and tumor histology. The utility of the revised Bethesda guidelines and published predictive pathology models for MSI-H colorectal carcinomas (PREDICT and MSPath) were evaluated. Left-sided MSI-H colorectal carcinomas were more frequently associated with LS compared with right-sided MSI-H colorectal carcinomas (12/21, 57% versus 26/129, 20%, P =.0008). There was no significant difference in histology between sporadic MSI-H and LS/probable LS-associated colorectal carcinomas except for a slightly higher proportion of sporadic MSI-H tumors demonstrating tumor-infiltrating lymphocytes (81% versus 61%, P =.015). Neither pathology predictive model identified all LS-associated colorectal carcinomas (PREDICT: 33/38, 87%; MSPath: 35/38, 92%). 12/117 (10%) MSI-H colorectal carcinomas identified in patients >60 years were LS/probable LS-associated. Our results demonstrate that models of predicting MSI-H fail to identify LS-associated colorectal carcinoma given their reliance on right-sided location. A significant proportion (32%) of LS-associated colorectal carcinoma is identified in patients >60 years. Finally, our results demonstrate similar morphologic features between LS-associated and sporadic MSI-H colorectal carcinomas.
机译:筛查大肠癌患者的Lynch综合征(LS)的最佳策略是文献中不断争论的主题,有些主张普适性筛查,而另一些主张选择性筛查。我们评估了1292个大肠癌的DNA错配修复蛋白异常,并鉴定出150个(11.6%)肿瘤,表现出高水平的微卫星不稳定性(MSI-H)。基于BRAF V600E突变,MLH1启动子过度甲基化,癌症病史和种系错配修复,MSI-H大肠癌分为零星(112 / 1292,8.7%)和LS /可能与LS相关(38 / 1292,2.9%)的组基因突变。分析所有MSI-H大肠癌的等级,位置和肿瘤组织学。评估了修订的Bethesda指南和已发布的MSI-H大肠癌预测性病理模型(PREDICT和MSPath)的实用性。与右侧MSI-H大肠癌相比,左侧MSI-H大肠癌与LS发生率更高(12 / 21,57%对26 / 129,20%,P = .0008)。散发性MSI-H和LS /可能的LS相关结直肠癌的组织学无显着差异,只是散发性MSI-H肿瘤的淋巴细胞浸润率略高(81%比61%,P = .015) 。两种病理学预测模型均未鉴定出所有与LS相关的结直肠癌(PREDICT:33 / 38,87%; MSPath:35 / 38,92%)。在60岁以上的患者中鉴定出的12/117(10%)MSI-H大肠癌与LS /可能与LS相关。我们的结果表明,鉴于MSI-H预测模型依赖于右侧位置,因此无法识别LS相关的结直肠癌。在> 60岁的患者中发现了很大一部分(32%)的LS相关的结直肠癌。最后,我们的结果证明了LS相关散发性MSI-H大肠癌的形态特征相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号